AZZARA', ANTONIO
 Distribuzione geografica
Continente #
NA - Nord America 13.728
AS - Asia 8.100
EU - Europa 6.632
SA - Sud America 740
AF - Africa 213
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 29.433
Nazione #
US - Stati Uniti d'America 13.274
CN - Cina 2.861
IT - Italia 2.312
SG - Singapore 2.273
HK - Hong Kong 1.099
SE - Svezia 1.063
BR - Brasile 632
DE - Germania 556
VN - Vietnam 556
GB - Regno Unito 535
BG - Bulgaria 515
KR - Corea 498
UA - Ucraina 422
CA - Canada 398
TR - Turchia 389
FI - Finlandia 334
FR - Francia 244
CH - Svizzera 223
RU - Federazione Russa 221
CI - Costa d'Avorio 126
IN - India 121
JP - Giappone 66
BD - Bangladesh 41
IQ - Iraq 38
BE - Belgio 37
AR - Argentina 35
NL - Olanda 32
MX - Messico 28
PL - Polonia 26
SA - Arabia Saudita 22
ZA - Sudafrica 22
AT - Austria 21
UZ - Uzbekistan 18
GR - Grecia 16
ID - Indonesia 15
ES - Italia 14
CO - Colombia 13
PH - Filippine 13
PK - Pakistan 13
VE - Venezuela 13
UY - Uruguay 12
IL - Israele 11
KE - Kenya 11
MA - Marocco 11
NG - Nigeria 10
PY - Paraguay 10
CZ - Repubblica Ceca 9
JO - Giordania 9
TN - Tunisia 9
AU - Australia 8
BO - Bolivia 8
IE - Irlanda 8
JM - Giamaica 8
SN - Senegal 7
AZ - Azerbaigian 6
BJ - Benin 6
EC - Ecuador 6
EU - Europa 6
NP - Nepal 6
AL - Albania 5
CL - Cile 5
MY - Malesia 5
OM - Oman 5
PE - Perù 5
AE - Emirati Arabi Uniti 4
BB - Barbados 4
HU - Ungheria 4
IR - Iran 4
IS - Islanda 4
KZ - Kazakistan 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
DK - Danimarca 3
EE - Estonia 3
EG - Egitto 3
LT - Lituania 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RS - Serbia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
HR - Croazia 2
KG - Kirghizistan 2
LY - Libia 2
MD - Moldavia 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
CD - Congo 1
GD - Grenada 1
Totale 29.419
Città #
Woodbridge 1.529
Ann Arbor 1.341
Singapore 1.309
Ashburn 1.174
Hong Kong 1.088
Chandler 999
Houston 969
San Jose 693
Hefei 655
Fairfield 637
Shanghai 617
Santa Clara 609
Jacksonville 550
Milan 536
Sofia 510
Seoul 492
Beijing 408
Dallas 373
Ottawa 347
New York 311
Seattle 298
Wilmington 267
Izmir 254
Cambridge 243
Boardman 228
Lancaster 226
Princeton 202
Lawrence 196
Bern 191
Nanjing 187
Lauterbourg 175
Los Angeles 154
Dearborn 150
Des Moines 137
Medford 137
Abidjan 126
Serra 126
Dong Ket 109
Regensburg 109
Ho Chi Minh City 106
Istanbul 105
Boulder 95
Buffalo 94
Chicago 94
Hanoi 94
Jüchen 93
Nanchang 84
Rome 79
Council Bluffs 66
London 62
Tokyo 62
Helsinki 61
Florence 57
São Paulo 56
Kunming 52
Frankfurt am Main 49
Redondo Beach 48
San Diego 41
Columbus 40
The Dalles 38
Munich 37
Redwood City 37
Brussels 35
Fuzhou 33
Shenyang 32
Jiaxing 31
Orem 30
Hebei 29
Ogden 28
Changsha 26
Pune 24
Tianjin 24
Turin 24
Zurich 24
Naples 23
Norwalk 22
Catania 21
Hangzhou 21
Orange 21
Quanzhou 21
Bremen 20
Da Nang 20
Turku 20
Westminster 20
Lanzhou 18
Tashkent 18
Vienna 18
Warsaw 18
Pisa 17
Rio de Janeiro 17
Verona 17
Alessandria 16
Auburn Hills 16
Belo Horizonte 16
Curitiba 16
Falls Church 15
Guangzhou 15
Sorocaba 15
Chennai 14
Dhaka 14
Totale 21.021
Nome #
I farmaci collaterali e i farmaci controindicati nell'emofilia e nella malattia di Willebrand 1.158
Non-myeloablative allogeneic peripheral stem cell transplant in a patient with metastatic melanoma 367
H-3 NECA BINDING TO POLYMORPHONUCLEAR MEMBRANE - EFFECT OF SERA FROM PATIENTS WITH HODGKINS-DISEASE 287
B-cell acute lymphoblastic leukemia with t(4;11)(q21;q23) in a young woman: evolution into mixed phenotype acute leukemia with additional chromosomal aberrations in the course of therapy. 259
Glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor differently modifies actin polymerization in neutrophils 252
Glycosylation interference on RhoA activation: focus on G-CSF 235
F-mlp-induced CD11/CD18 up-regulation on PMNs from patients with rhG-CSF 232
Infliximab treatment of grade IV skin acute graft versus host disease 215
Severe pancytopenia due to copper deficiency 211
CD229 expression on bone marrow plasma cells from patients with multiple myeloma and monoclonal gammopathies of uncertain significance 211
Alteraciones funcionales de los granulocitos neutrofilos en un joven neutropenico de raza negra 208
Immunomodulators and enzymes of purine metabolism in human lymphocytes 207
Modifications in B-Lymphocyte Number and Phenotype in the Course of Pregnancy in a Woman with Persistent Polyclonal B-Cell Lymphocytosis: A Flow Cytometric Study 207
Il G-CSF: differenti attività della formulazione glicosilata e non glicosilata sulle funzioni granulocitarie 204
The effects of lithium and rubidium on human leukocyte functions 202
Leukotriene production by human vascular tissues: possible link between the nature of the atherosclerotic lesions and their clinical activity 198
A case of Staphylococcal toxic shock syndrome with expansion of TCR alphaBeta+, CD4/CD8 double negative lymphocytes 196
In vivo and in vitro effects of thymostimulin (TP-1) on immunodeficiencies 195
Moderately differentiated lymphocytic lymphoma mainly with bone involvement 193
Impact of a new dosing regimen of epoetin alfa on quality of life and anemia in patients with low-risk myelodysplastic syndrome 191
Inhibition of neutrophil oxidative metabolism by trichinellosis patient sera 190
PS-341 (Bortezomid) inhibits both proliferation of megakaryoblastic cells in vitro and MK colonies production in patients affected by idiopathic myelofibrosis 190
Predictive role of WT1 and RPS14 expression in patients affected by myelodysplastic syndromes receiving azacitidine 186
MDS: An Integrated Workup for a Correct Diagnosis 184
Mrthisoprinol (Viruxan): Restoration of leukocyte chemotaxis inhibited by sera from patients with Hodgkin's Disease 183
Increased PHA response to thymostimulin in the elderly 182
5-lipoxygenase activity in the human vessel wall 182
L'eritrofagocitosi nelle empoatie maligne 182
Immunological criteria in prognostic evaluation of polichemotherapy in Hodgkin's disease 181
Unusual morphology in a case of large granular cell leukemia 180
Myelomatous meningitis evaluated by multiparameter flow cytometry : report of a case and review of the literature 180
Infective complications in oncohaematology: a study on the i.v. administration of polyvalent antibodies 178
Lymphocytic and granulocytic functions in patients with lymphoadenopathy syndrome (LAS) 178
Leukocyte migration inhibitory activity in the serum of patients affected by Hodgkin's disease and other immunoproliferative diseases 178
Inhibition of leukocyte function by serum from patients with trichinellosis 177
Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA 177
Sepsi ricorrenti correlate a ridotte funzioni granulocitarie e immunomodulazione con metisoprinolo. Rilievi su una casistica pediatrica 175
Hairy Cell Leukemia: morfologia e citochimica 175
Chemotaxis inhibitory activity in serum of patients with malignant paraproteinemia 174
ADA e PNP intralinfocitarie in soggetti anziani. Effetti della timostimolina 173
Enzymes intra-lymphocytaires du metabolisme purinique et immuno-modulation 173
Morphologic and immunophenotypic features of a case of acute monoblastic leukemia with unusual positivity for Glycophorin-A. 173
1,25-dihidroxy-vitamin d3 (1,25(OH)2D3) in the treatment of idiopathic myelofibrosis 172
Evaluation of neutrophil motility by image analysis 171
Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor 171
The hypotesis of phospholipase inhibition by glucocorticoids: an evaluation in vivo 170
A workstation for measurement and processing of the motility parameters of resting and stimulated granulocytes 169
FcRIII (CD16) ontogeny in human myeloid cells. A flow cytometry study on circulating neutrophils from chronic myeloid leukemia 169
A whole blood flow cytometric method to evaluate F-actin polymerization in neutrophils 168
Prethymic cytoplasmic CD3 negative acute lymphoblastic leukemia or acute undifferentiated leukemia: a case report 168
Sorafenib as monotherapy or in association with cytarabine and clofarabine for the treatment of relapsed/refractory FLT3 ITD-positive advanced acute myeloid leukemia 168
Contemporaneous appearance, 18 years after allogeneic bone marrow transplantation, of myelodysplastic syndrome in the patient and the donor 167
Ruolo di un inibitore delle prostaglandine (Indinetacina) sulla riserva midollare 166
Methisoprinol restoration of leukocyte chemotaxis inhibition by blocking factors in immunproliferative diseases 166
PLATELET-DERIVED GROWTH FACTOR BETA RECEPTOR (PDGFRB) GENE IS REARRANGED IN A SIGNIFICANT PERCENTAGE OF MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE 166
Evaluation of adriamycin toxicity by means of determination of serum CK-MB and myoglobin concentration in man 165
Abnormal motility patterns of neutrophils in myelodisplastic syndromes identified by image analysis 165
The role of CD200 expression in differential diagnosis among Non Hodgkin Lymphoma 165
1,25-dihydroxycholecalciferol inhibits the cochemotactic activity of Gc (vitamin D binding protein) 165
Multidrug resistance in acute myeloid leukemia: significance of MDR1, BCRP, WT1 genes quantitative expression and of FLT3-ITD 164
Behavior of some enzymes of nucleoside catabolism in circulating lymohocytes during paraproteinemia 163
Methisoprinol(Viruxan): effects on phagocytosis in Hodgkin's Disease 163
Morphological features of rhG-CSF-induced neutrophils 163
Actin polymerization in neutrophils from patients affected by myelodysplastic syndromes - A flow cytometric study 162
Leukotriene B4 production in human atherosclerotic plaques 161
Pseudoreticulocytosis in a case of myelodysplastic syndrome 161
Facteurs inhibant le chimiotactisme au cours des maladies immunoproliferatives: antagonisme in vivo de l'isoprinosine 160
Human neutrophil microtubular system: in vitro and in vivo evidence of lithium inteference 160
About copper deficiency. Reply 159
Use of the Blob Analysis in the development of a new procedure for the automatic count of granulocytes migrating through micropore filters in chemotactic Boyden chamber 159
Carboxy-terminal fragment of osteogenic growth peptide activity on essential thrombocytemia 159
Motility of rhG-CSF-induced neutrophils in patients undergoing chemotherapy: evidence for inhibition detected by image analysis. 159
Leukocyte chemotaxis modifications and specific IgE concentration during maximal pollen air pollution 158
Painful neuropathy, monoclonal gammopathy and amyloid deposit: response to treatmente in 3 cases. 158
Luminol-enhanced, whole blood chemiluminescence of human neutrophils evaluated by means of an automated, computer-assisted, and high-sensitivity luminescence analyzer 158
Effetti in vitro di immunoglobuline per uso endovenoso (IVIG) sull'attivazione dei T-linfociti 157
Rosette E e curva dose-risposta alla fitoemoagglutinina nelle paraproteinemie 156
Clarkson's syndrome: a rare systemic disease mimicking haematological disorders 156
Multiparameter Flow Cytometry to Detect Hematogones and to Assess B-lymphocyte clonality in Bone Marrow Samples from Patients with Non-Hodgkin Lymphomas 156
Lymphocyte functions in B-chronic lymphatic leukaemia (B-CLL): modulation by the association arginine-lysine-potassium 154
Attività sierica inibente la chemiotassi e la fagocitosi di neutrofili umani in pazienti affetti da trichinellosi 154
Bone and bone marrow interactions: hematological activity of osteoblastic growth peptide (OGP)-derived carboxy-terminal pentapeptide; III. Action on human megakaryocytopoiesis: focus on essential thrombocythemia 154
Neutrophil aggregation and receptors masking in chronic myeloid leukemia 153
Two Cases of Plasma Cell Leukemia with Atypical Immunophenotype 150
Detection of eosinophils in whole blood samples by flow cytometry 149
Low RPS14 expression negatively conditions the prognosis of patients affected by not 5q- myelodysplastic syndromes during azacitidine treatment 148
Defective neutrophil chemotaxis in Shwachman-Diamond Syndrome: restoration after lithium therapy 147
rhG-CSF-induced phenotypic changes of neutrophils from patients undergoing autologous PBSC transtantation 145
Autologous transplantation with Philadelphia chromosome negative stem cells mobilized in first chronic phase-chronic myeloid leukaemia 145
Effect of a new dosing regimen of epoietin alfa on anemia and quality of life in low risk myelodysplastic syndrome patients 144
Interferenza della nicardipina con l'icorporazione di uridina in linfociti normali ed in cellule leucemiche 143
BK virus-associated cystitis in non-myeloablative and conventional transplant recipients with simultaneous cytomegalovirus reactivation successfully treated with cydofovir. 143
Allogenic peripheral blood stem cell transplantation following a non-myeloablative (NMST) conditioning with fludarabine and low dose TBI in patients with haematological malignancies and metastatic melanoma: a single-center experience 142
R-IPSS, RPS14 AND WT1 LEVELS ARE THE BEST PROGNOSTIC FACTORS FOR PATIENTS AFFECTED BY MYELODYSPLASTIC SYNDROMES DURING AZACITIDINE TREATMENT. 142
Effects of thymostimulin on human lymphocyte adenosine deaminase and purine nucleoside phosphorylase activities: phisiological and therapeutic effects 141
A trichinella Spiralis glycoprotein different from N.I.F. modulates CD11B up-regulation of activated neutrophils 141
Transitory marrow aplasia during Imatinib therapy in a patient with chronic myeloid leukemia 141
LEGO® bricks used as chemotactic chambers: evaluation by a computer-assisted image analysis technique 141
Phenotypic changes in neutrophils after rhG-CSF administration in non-Hodgkin's lymphoma patients undergoing PBSC transplantation or conventional chemotherapy. 140
The role of CD19 and CD27 in the diagnosis of Multiple Myeloma by Flow Cytometry: a new statistical model. 139
Totale 18.478
Categoria #
all - tutte 72.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 72.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021273 0 0 0 0 0 0 0 0 0 0 0 273
2021/20222.066 23 172 19 159 429 281 36 104 116 71 97 559
2022/20232.815 338 312 213 246 308 413 31 253 458 20 184 39
2023/20242.412 415 213 298 124 303 332 98 145 48 98 70 268
2024/20256.040 60 237 28 418 410 422 679 352 590 776 794 1.274
2025/20265.541 354 1.028 587 377 429 625 1.045 286 208 424 131 47
Totale 29.558